2020 annual financial data

Sutro Biopharma 2020 Operating margin

Direct answer

Operating margin was -166.32%.

Operating income was -71.06M USD and net income was -32.13M USD.
Operating cash flow was -67.8M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42.72M USD
Operating income
-71.06M USD
Net income
-32.13M USD
Operating cash flow
-67.8M USD